Peptic Ulcer – Top USMLE Diseases

Peptic Ulcer – Top USMLE Diseases

by Carlo Raj, MD, Charles Vega, MD

This course covers everything you need to know about Peptic Ulcers.

Raise your test scores with the support of high quality videos today!

Course Details

  • Videos 4
  • Duration 0:22 h
  • Quiz questions 15
  • Articles 2


Your Educators of course Peptic Ulcer – Top USMLE Diseases

 Carlo Raj, MD

Carlo Raj, MD

Dr. Carlo Raj is a Physician and Lecturer at Becker’s Healthcare in Illinois, USA, and the CEO and founder of Indus Intellect Virtual MedEd, a medical education consulting company.
He obtained his MD from Medical University of the Americas (MUA) and is an international lecturer and public speaker.
Within Lecturio, Dr. Raj teaches courses on Cellular Pathology, Ophthalmology, and Hepatology.

 Charles Vega, MD

Charles Vega, MD

Dr. Charles Vega is the Health Sciences Clinical Professor of Family Medicine at the University of California, Irvine in California, USA.
He obtained his Medical Degree from the University of Wisconsin, and completed residency training in Family Medicine at UC Irvine. Currently, he is the Executive Director of UCI’s Program in Medical Education for the Latino Community.
Due to his achievements, he earned a Macy Faculty Scholarship to improve patient-centered health education at UCI.
Within Lecturio, Dr. Vega teaches courses on Family Medicine.

User reviews

4,5 of 5 stars
5 Stars
4 Stars
3 Stars
2 Stars
1  Star
Key points well covered.
By S C. on 07. August 2021 for Helicobacter Pylori Infection

good review of the topic. I am unsure why someone has given it 3 stars. Cant fault it.

Key points well covered.
By S C. on 07. August 2021 for NSAIDs Induced Peptic Ulcer Disease

such a good lecuture. Covers the topic in a broad sense. good clinical value.

By Husain D. on 21. June 2021 for Peptic Ulcer Disease

great tutor, very informative and direct to the point helped a lot

Can be improved
By Hamed S. on 09. March 2017 for Helicobacter Pylori Infection

It would would have been good to further elaborate on dx testing and in which clinical circumstances one would be more appropriate over the other. Also with the increasing incidence of resistant organisms I feel the lecture didn't adequately outline appropriate second line management. Also the error regarding PPI which was flagged by another listener